StockSelector.com
  Research, Select, & Monitor Wednesday, February 19, 2020 4:41:00 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Amgen, Inc.$221.69($1.79)(.80%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Amgen, Inc. has an overall rank of 519 out of 6025 stocks based on 15 positive rankings and 8 negative rankings.

Positive Rankings
Highest ROE
Amgen rank is 29
Top Industry Values
Amgen rank is 41
Highest Net Margin
Amgen rank is 122
Highest ROA
Amgen rank is 154
Highest Cash Growth
Amgen rank is 323
Beat Whisper
According to EarningsWhispers.com, Amgen beat the Earnings Whisper number when it last reported earnings. Statistics show that companies that have beat the Earnings Whisper number outperform the market in the short-term.
Estimated Revenue Growth
Amgen rank is 429
Estimated EPS Growth
Amgen rank is 481
Historic EPS Growth
Amgen rank is 644
Up EPS Surprise
Amgen beat the consensus earnings estimate when it last reported quarterly earnings.
Target Prices
The average analysts' target price is $232.50 for Amgen using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Amgen is ranked 966.
SSValue
The StockSelector Value for Amgen is $246.82. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Amgen is ranked 1136.
Historic Revenue Growth
Amgen rank is 1302
90 Day Gain
Amgen rank is 1799
10 Day Gain
Amgen rank is 2243
Negative Rankings
Down Ratings Revision
During the past month, the average analyst's rating or recommendation has decreased. Among companies that have been downgraded within the past month, Amgen is ranked 38.
Price-to-Book
Amgen rank is 110
Negative Guidance
Within the past 90 days Amgen has provided guidance belwo the consensus estimates. Statistics show companies that provide negative guidance underperform the market in the short-term.
Negative MACD Cross
The MACD Divergence has recently become negative while the MACD remains positive. This is typically a negative short-term indicator.
Debt-to-Equity
Amgen rank is 256
Price-to-Sales
Amgen rank is 361
High Put/Call
Amgen has a high Put/Call ratio of 0.73 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Amgen is ranked 1277.
High vPut/Call
Amgen has a high Put/Call ratio of 0.71 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Amgen is ranked 1668.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2020 StockSelector.com. All rights reserved.